Brief: Sutro Biopharma Q3 Revenue USD 8.52 Million
13/11/2024 21:30
Nov 13 (Reuters) - Sutro Biopharma Q3 operating income USD -67.919 million. * Q3 operating expenses USD 76.439 million * Q3 basic EPS USD -0.59 * Q3 net income USD -48.787 million
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates